Together, our study reveals previous unrecognized role of RPLP2 in HCC, and provides new regulatory mechanism of ferroptosis, indicating RPLP2 may be a novel therapeutic target for HCC. This evidence concerns the gene RPLP2 and hepatocellular carcinoma.